These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2663805)

  • 21. Beta-lactamase evaluation of the amoxycillin-clavulanate association.
    Novelli A; Reali EF; Fallani S; Periti P
    Drugs Exp Clin Res; 1989; 15(4):151-4. PubMed ID: 2505995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A piperacillin-tazobactam resistant Escherichia coli strain isolated from a faecal sample of a healthy volunteer.
    London N; Thomson CJ; Amyes SG; Stobberingh E
    FEMS Immunol Med Microbiol; 1995 Apr; 11(2):107-11. PubMed ID: 7640670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combined antibacterial activity of clavulanic acid with amoxicillin and ampicillin against Gram-negative strains].
    Mascellino MT; Prignano G; Lorenzi A; Iegri F; Martorano E; Catania S; Ginanni Corradini S
    Boll Ist Sieroter Milan; 1984; 63(5):447-52. PubMed ID: 6335660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2.
    Payne DJ; Marriott MS; Amyes SG
    J Med Microbiol; 1990 Jun; 32(2):131-4. PubMed ID: 2192063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amoxycillin/clavulanate resistant Escherichia coli.
    French G; Ling T
    Lancet; 1988 Mar; 1(8587):704. PubMed ID: 2895231
    [No Abstract]   [Full Text] [Related]  

  • 26. OHIO-1 beta-lactamase resistant to mechanism-based inactivators.
    Bonomo RA; Currie-McCumber C; Shlaes DM
    FEMS Microbiol Lett; 1992 Apr; 71(1):79-82. PubMed ID: 1320587
    [No Abstract]   [Full Text] [Related]  

  • 27. Small plasmids are involved in amoxicillin-clavulanate resistance in Escherichia coli.
    Martinez JL; Vicente MF; Delgado-Iribarren A; Perez-Diaz JC; Baquero F
    Antimicrob Agents Chemother; 1989 Apr; 33(4):595. PubMed ID: 2658797
    [No Abstract]   [Full Text] [Related]  

  • 28. An in-vitro and in-vivo comparison of the activity of beta-lactamase inhibitor combinations with imipenem and cephalosporins against Escherichia coli producing TEM-1 or TEM-2 beta-lactamase.
    Cherubin CE; Eng RH; Smith SM; Tan EN
    J Antimicrob Chemother; 1991 Jul; 28(1):61-70. PubMed ID: 1769944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TEM-1 plasmids in the community.
    Thomson CJ; Shanahan PM; Amyes SG
    Lancet; 1994 Apr; 343(8902):921. PubMed ID: 7908384
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of low concentrations of clavulanic acid on the in-vitro activity of amoxycillin against beta-lactamase-producing Branhamella catarrhalis and Haemophilus influenzae.
    Cooper CE; Slocombe B; White AR
    J Antimicrob Chemother; 1990 Sep; 26(3):371-80. PubMed ID: 2121699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective ceftazidime resistance in Escherichia coli: association with changes in outer membrane protein.
    Bakken JS; Sanders CC; Thomson KS
    J Infect Dis; 1987 Jun; 155(6):1220-5. PubMed ID: 3553348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Characterization of the resistance to combinations of beta lactams and inhibitors of beta-lactamases in Escherichia coli. Effect of the type and amount of beta-lactamase production].
    del Mar Pérez-Moreno M; Pous-Miralles G; Romera-Sastre G; Panisello-Bertomeu JM; Jardí-Baiges AM; Zarazoga-López J
    Enferm Infecc Microbiol Clin; 1997 Nov; 15(9):477-81. PubMed ID: 9527373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microcalorimetric, turbidimetric, phase-contrast microscopic, and electron microscopic investigations of the actions of amoxicillin, clavulanic acid and augmentin on amoxicillin-sensitive and amoxicillin-resistant strains of Escherichia coli.
    Semenitz E; Casey PA; Pfaller W; Gstraunthaler G
    Chemotherapy; 1983; 29(3):192-207. PubMed ID: 6347546
    [No Abstract]   [Full Text] [Related]  

  • 34. [Bacterial growth delay in E. coli: demonstration and evaluation of the beta-lactamase post-inhibitor effect on 6 strains with different resistance phenotypes].
    Murbach V; Bronner S; Dhoyen N; Sougakoff W; Monteil H; Jehl F
    Pathol Biol (Paris); 2000 Jun; 48(5):478-84. PubMed ID: 10949845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
    Jacobs MR; Spangler SK; Appelbaum PC
    J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance to amoxicillin/clavulanate in Escherichia coli.
    Colaert J
    Acta Clin Belg; 1992; 47(5):353-4. PubMed ID: 1334324
    [No Abstract]   [Full Text] [Related]  

  • 37. Transferable cephalosporin resistance not inhibited by clavulanate in Escherichia coli.
    Woodford N; Payne DJ; Johnson AP; Weinbren MJ; Perinpanayagam RM; George RC; Cookson BD; Amyes SG
    Lancet; 1990 Jul; 336(8709):253. PubMed ID: 1973805
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical isolates of Escherichia coli producing TRI beta-lactamases: novel TEM-enzymes conferring resistance to beta-lactamase inhibitors.
    Vedel G; Belaaouaj A; Gilly L; Labia R; Philippon A; Névot P; Paul G
    J Antimicrob Chemother; 1992 Oct; 30(4):449-62. PubMed ID: 1490918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resistance to amoxicillin/clavulanate in Escherichia coli.
    Lontie M
    Acta Clin Belg; 1992; 47(2):131. PubMed ID: 1321539
    [No Abstract]   [Full Text] [Related]  

  • 40. Resistance to amoxicillin/clavulanate in Escherichia coli.
    Glupczynski Y; Mac Gillavry G; Yourassowsky E
    Acta Clin Belg; 1992; 47(5):354-5. PubMed ID: 1334325
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.